シンバイオ製薬（4582）の空売り残高
シンバイオ製薬（4582）の現在の空売り残高は 2,859,647株、対発行株数の割合は 3.75% です（2026-06-16公表時点、4機関が報告）。
空売り残高（合計）の推移
- Barclays Capital Securities
- GOLDMAN SACHS
- JPM Securities Japan Co
- Nomura
- UBS
- モルガン・スタンレーMUFG証券
- Macquarie Bank
- Citigroup Global Markets
- MERRILL LYNCH
- JANE STREET GLOBAL TRADING
空売り者ごとの積み上げ（直近半年）。下の表は合計を最大12ヶ月分の数値で掲載。
繰越を反映した営業日ごとの空売り残高 合計（新しい順・直近90日を表示）。
| 計算日 | 残高数量（合計） | 残高割合 |
|---|---|---|
| 2026/06/16 | 2,859,647 | 3.75% (0.00%) |
| 2026/06/15 | 2,859,647 | 3.75% (0.00%) |
| 2026/06/12 | 2,859,647 | 3.75% (+0.11%) |
| 2026/06/11 | 2,776,847 | 3.64% (+0.28%) |
| 2026/06/10 | 2,553,519 | 3.36% (+0.53%) |
| 2026/06/09 | 2,141,880 | 2.83% (+0.15%) |
| 2026/06/08 | 2,028,580 | 2.68% (+0.17%) |
| 2026/06/05 | 1,900,780 | 2.51% (-0.11%) |
| 2026/06/04 | 1,987,780 | 2.62% (-0.12%) |
| 2026/06/03 | 2,074,480 | 2.74% (-0.16%) |
| 2026/06/02 | 2,197,080 | 2.90% (-0.09%) |
| 2026/06/01 | 2,259,080 | 2.99% (+0.13%) |
| 2026/05/29 | 2,155,480 | 2.86% (+0.17%) |
| 2026/05/28 | 2,030,780 | 2.69% (0.00%) |
| 2026/05/27 | 2,025,180 | 2.69% (0.00%) |
| 2026/05/26 | 2,025,180 | 2.69% (0.00%) |
| 2026/05/25 | 2,025,180 | 2.69% (+0.08%) |
| 2026/05/22 | 1,968,280 | 2.61% (+0.04%) |
| 2026/05/21 | 1,936,780 | 2.57% (-0.10%) |
| 2026/05/20 | 2,011,780 | 2.67% (-0.10%) |
| 2026/05/19 | 2,088,580 | 2.77% (-0.18%) |
| 2026/05/18 | 2,228,980 | 2.95% (-0.12%) |
| 2026/05/15 | 2,317,880 | 3.07% (-0.53%) |
| 2026/05/14 | 2,721,780 | 3.60% (-0.04%) |
| 2026/05/13 | 2,747,980 | 3.64% (0.00%) |
| 2026/05/12 | 2,747,980 | 3.64% (+0.63%) |
| 2026/05/11 | 2,275,480 | 3.01% (0.00%) |
| 2026/05/08 | 2,275,480 | 3.01% (-0.62%) |
| 2026/05/07 | 2,743,380 | 3.63% (-0.15%) |
| 2026/05/01 | 2,832,880 | 3.78% (-0.10%) |
機関別の空売り残高（過去12ヶ月の報告）
直近12ヶ月の機関別 空売り残高の報告（計算日の新しい順、全568件中 直近90件を表示）。
| 空売り者 | 計算日 | 残高数量 | 残高割合 |
|---|---|---|---|
| モルガン・スタンレーMUFG証券 | 4/6 | 631,427 | 0.87% (-0.03%) |
| Nomura | 4/2 | 1,615,921 | 2.24% (-0.14%) |
| GOLDMAN SACHS | 4/2 | 914,804 | 1.27% (-0.05%) |
| UBS | 4/2 | 433,600 | 0.60% (+0.01%) |
| Nomura | 4/1 | 1,715,098 | 2.38% (-0.11%) |
| GOLDMAN SACHS | 4/1 | 949,204 | 1.32% (+0.08%) |
| UBS | 4/1 | 424,900 | 0.59% (-0.01%) |
| GOLDMAN SACHS | 3/31 | 894,304 | 1.24% (+0.09%) |
| Macquarie Bank | 3/31 | 0 | 0.00% (-0.79%) |
| Nomura | 3/30 | 1,791,194 | 2.49% (-0.04%) |
| GOLDMAN SACHS | 3/30 | 830,604 | 1.15% (-0.14%) |
| UBS | 3/30 | 431,700 | 0.60% (+0.01%) |
| Nomura | 3/27 | 1,821,328 | 2.53% (-0.12%) |
| GOLDMAN SACHS | 3/27 | 932,604 | 1.29% (-0.20%) |
| Citigroup Global Markets | 3/27 | 357,400 | 0.49% (-0.20%) |
| モルガン・スタンレーMUFG証券 | 3/26 | 652,527 | 0.90% (+0.04%) |
| Nomura | 3/25 | 1,910,176 | 2.65% (-0.41%) |
| GOLDMAN SACHS | 3/25 | 1,074,204 | 1.49% (-0.09%) |
| モルガン・スタンレーMUFG証券 | 3/25 | 622,027 | 0.86% (-0.04%) |
| Citigroup Global Markets | 3/25 | 498,200 | 0.69% (-0.05%) |
| UBS | 3/25 | 424,600 | 0.59% (-0.04%) |
| Nomura | 3/24 | 2,199,642 | 3.06% (-0.21%) |
| Barclays Capital Securities | 3/24 | 335,304 | 0.46% (-0.28%) |
| Nomura | 3/23 | 2,354,729 | 3.27% (-0.18%) |
| JPM Securities Japan Co | 3/23 | 845,751 | 1.17% (-0.05%) |
| モルガン・スタンレーMUFG証券 | 3/23 | 652,627 | 0.90% (-0.11%) |
| Barclays Capital Securities | 3/23 | 535,304 | 0.74% (-0.41%) |
| Nomura | 3/19 | 2,482,294 | 3.45% (-0.46%) |
| GOLDMAN SACHS | 3/19 | 1,142,304 | 1.58% (-0.07%) |
| JPM Securities Japan Co | 3/19 | 879,451 | 1.22% (-0.13%) |